Literature DB >> 3322656

Saccharomyces cerevisiae fungemia: case report and review of the literature.

N Cimolai1, M J Gill, D Church.   

Abstract

Saccharomyces cerevisiae was isolated on two separate occasions from the blood of a patient with chronic renal failure receiving dialysis. Treatment was complicated by recurrent ventricular tachycardia occurring after both 1 mg and 0.1 mg test doses of amphotericin. We report the unique clinical and microbiological aspects of this patient's management, and review the literature pertinent to this organism.

Entities:  

Mesh：

Year:  1987        PMID： 3322656     DOI： 10.1016/0732-8893(87)90158-1

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  14 in total

1.  Oxidative stress survival in a clinical Saccharomyces cerevisiae isolate is influenced by a major quantitative trait nucleotide.

Authors:  Stephanie Diezmann; Fred S Dietrich
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

2.  Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method.

Authors:  M J McCullough; K V Clemons; C Farina; J H McCusker; D A Stevens
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 3.  Saccharomyces cerevisiae pneumonia in a patient with acquired immune deficiency syndrome.

Authors:  O W Tawfik; C J Papasian; A Y Dixon; L M Potter
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

4.  Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates.

Authors:  B Posteraro; M Sanguinetti; G D'Amore; L Masucci; G Morace; G Fadda
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 5.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae.

Authors:  J H McCusker; K V Clemons; D A Stevens; R W Davis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Disseminated infection with Saccharomyces kluyveri in a patient with AIDS.

Authors:  M Pynka; A Wnuk; D Bander; M Syczewska; A Boroń; B Prost; S Wrzecion
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

8.  Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.

Authors:  J K Byron; K V Clemons; J H McCusker; R W Davis; D A Stevens
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Genetic characterization of pathogenic Saccharomyces cerevisiae isolates.

Authors:  J H McCusker; K V Clemons; D A Stevens; R W Davis
Journal:  Genetics       Date:  1994-04       Impact factor: 4.562

Review 10.  Emerging fungal pathogens.

Authors:  E J Anaissie; G P Bodey; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.